Phase Ib Trial of the Toll-like Receptor 8 Agonist, Motolimod (VTX-2337), Combined with Cetuximab in Patients with Recurrent or Metastatic SCCHN von Chow, Laura Q M, Morishima, Chihiro, Eaton, Keith D, Baik, Christina S, Goulart, Bernardo H, Anderson, Leslie N, Manjarrez, Kristi L, Dietsch, Gregory N, Bryan, James Kyle, Hershberg, Robert M, Disis, Mary L, Martins, Renato G

Volltext

Head and Neck Cancer von Chow, Laura Q.M

Volltext

The Evolving Role of Immune Checkpoint Inhibitors in Cancer Treatment von Pennock, Gregory K., Chow, Laura Q.M.

Volltext

PD-L2 Expression in Human Tumors: Relevance to Anti-PD-1 Therapy in Cancer von Yearley, Jennifer H, Gibson, Christopher, Yu, Ni, Moon, Christina, Murphy, Erin, Juco, Jonathan, Lunceford, Jared, Cheng, Jonathan, Chow, Laura Q M, Seiwert, Tanguy Y, Handa, Masahisa, Tomassini, Joanne E, McClanahan, Terrill

Volltext

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer von Brahmer, Julie R, Tykodi, Scott S, Chow, Laura Q.M, Hwu, Wen-Jen, Topalian, Suzanne L, Hwu, Patrick, Drake, Charles G, Camacho, Luis H, Kauh, John, Odunsi, Kunle, Pitot, Henry C, Hamid, Omid, Bhatia, Shailender, Martins, Renato, Eaton, Keith, Chen, Shuming, Salay, Theresa M, Alaparthy, Suresh, Grosso, Joseph F, Korman, Alan J, Parker, Susan M, Agrawal, Shruti, Goldberg, Stacie M, Pardoll, Drew M, Gupta, Ashok, Wigginton, Jon M

Volltext

Ceritinib in ALK-Rearranged Non–Small-Cell Lung Cancer von Shaw, Alice T, Kim, Dong-Wan, Mehra, Ranee, Tan, Daniel S.W, Felip, Enriqueta, Chow, Laura Q.M, Camidge, D. Ross, Vansteenkiste, Johan, Sharma, Sunil, De Pas, Tommaso, Riely, Gregory J, Solomon, Benjamin J, Wolf, Juergen, Thomas, Michael, Schuler, Martin, Liu, Geoffrey, Santoro, Armando, Lau, Yvonne Y, Goldwasser, Meredith, Boral, Anthony L, Engelman, Jeffrey A

Volltext

Phase Ib Study of Utomilumab (PF-05082566), a 4-1BB/CD137 Agonist, in Combination with Pembrolizumab (MK-3475) in Patients with Advanced Solid Tumors von Tolcher, Anthony W, Sznol, Mario, Hu-Lieskovan, Siwen, Papadopoulos, Kyriakos P, Patnaik, Amita, Rasco, Drew W, Di Gravio, Donna, Huang, Bo, Gambhire, Dhiraj, Chen, Ying, Thall, Aron D, Pathan, Nuzhat, Schmidt, Emmett V, Chow, Laura Q M

Volltext

Systemic therapy of brain metastases: non-small cell lung cancer, breast cancer, and melanoma von Chamberlain, Marc C, Baik, Christina S, Gadi, Vijayakrishna K, Bhatia, Shailender, Chow, Laura Q M

Volltext

Immuno-oncology Trial Endpoints: Capturing Clinically Meaningful Activity von Anagnostou, Valsamo, Yarchoan, Mark, Hansen, Aaron R, Wang, Hao, Verde, Franco, Sharon, Elad, Collyar, Deborah, Chow, Laura Q M, Forde, Patrick M

Volltext

A Phase I Clinical Trial of AZD1775 in Combination with Neoadjuvant Weekly Docetaxel and Cisplatin before Definitive Therapy in Head and Neck Squamous Cell Carcinoma von Méndez, Eduardo, Rodriguez, Cristina P, Kao, Michael C, Raju, Sharat, Diab, Ahmed, Harbison, R Alex, Konnick, Eric Q, Mugundu, Ganesh M, Santana-Davila, Rafael, Martins, Renato, Futran, Neal D, Chow, Laura Q M

Volltext

Factors associated with time to EGFR TKI treatment in patients with non-squamous metastatic non-small-cell lung cancer von Marrett, Elizabeth, Kwong, Winghan Jacqueline, Chow, Laura Qm

Volltext

Immuno-oncology Clinical Trial Design: Limitations, Challenges, and Opportunities von Baik, Christina S, Rubin, Eric H, Forde, Patrick M, Mehnert, Janice M, Collyar, Deborah, Butler, Marcus O, Dixon, Erica L, Chow, Laura Q M

Volltext

Liquid Biopsy Assessment of Circulating Tumor Cell PD-L1 and IRF-1 Expression in Patients with Advanced Solid Tumors Receiving Immune Checkpoint Inhibitor von Kennedy, Laura C., Lu, Jun, Kuehn, Sydney, Ramirez, Arturo B., Lo, Edward, Sun, Yao, U’Ren, Lance, Chow, Laura Q. M., Chen, Zhengjia, Grivas, Petros, Kaldjian, Eric P., Gadi, Vijayakrishna K.

Volltext

Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans von Breitbach, Caroline J., Burke, James, Jonker, Derek, Stephenson, Joe, Haas, Andrew R., Chow, Laura Q. M., Nieva, Jorge, Hwang, Tae-Ho, Moon, Anne, Patt, Richard, Pelusio, Adina, Le Boeuf, Fabrice, Burns, Joe, Evgin, Laura, De Silva, Naomi, Cvancic, Sara, Robertson, Terri, Je, Ji-Eun, Lee, Yeon-Sook, Parato, Kelley, Diallo, Jean-Simon, Fenster, Aaron, Daneshmand, Manijeh, Bell, John C., Kirn, David H.

Volltext

The use of combination immunotherapies as front-line therapy for non-small-cell lung cancer von Santana-Davila, Rafael, Chow, Laura QM

Volltext

Lack of pharmacokinetic drug–drug interaction between ramucirumab and paclitaxel in a phase II study of patients with advanced malignant solid tumors von Chow, Laura Q. M., Smith, David C., Tan, Antoinette R., Denlinger, Crystal S., Wang, Ding, Shepard, Dale R., Chaudhary, Archana, Lin, Yong, Gao, Ling

Volltext

Exploring novel immune-related toxicities and endpoints with immune-checkpoint inhibitors in non-small cell lung cancer von Chow, Laura Q M

Volltext

P3.02a-015 Ceritinib as First-Line Therapy in Patients with ALK-Rearranged Non-Small Cell Lung Cancer: ASCEND-1 Subgroup Analysis von Shao-Weng Tan, Daniel, Felip, Enriqueta, Chow, Laura Qm, Sharma, Sunil, Urban, Patrick, Malet, Isabelle, Sutradhar, Santosh, Li, Siyu, Shaw, Alice

Volltext

P3.02a-015 Ceritinib as First-Line Therapy in Patients with ALK-Rearranged Non-Small Cell Lung Cancer: ASCEND-1 Subgroup Analysis: Topic: ALK Clinical von Shao-Weng Tan, Daniel, Felip, Enriqueta, Chow, Laura Qm, Sharma, Sunil, Urban, Patrick, Malet, Isabelle, Sutradhar, Santosh, Li, Siyu, Shaw, Alice

Volltext

Exploring Novel Immune-Related Toxicities and Endpoints with Immune-Checkpoint Inhibitors in Non-Small Cell Lung Cancer von Chow, Laura QM

Volltext